Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Shares withheld for taxes 10% owner gave up 1 shares (to pay taxes)
  2. 4 Open-market sale President and CEO sold 2,915 shares at an average $13.19 ($38,437)
  3. 4 Open-market sale Chief Accounting Officer sold 1,804 shares at an average $13.19 ($23,788)
  4. 4 Open-market sale President and CEO sold 2,958 shares at an average $11.62 ($34,360)
  5. 4 Open-market sale Chief Accounting Officer sold 1,809 shares at an average $11.61 ($21,009)
  6. 4 Open-market buy 10% owner bought 55,000 shares at $12.19 ($670,423)
  7. 4 Open-market buy 10% owner bought 19,335 shares at $9.64 ($186,372)
  8. 4 Grant or award Director acquired 7,828 shares (grant or award)
  9. 4 Grant or award Director acquired 7,828 shares (grant or award)
  10. 4 Grant or award Director acquired 7,828 shares (grant or award)
  11. 4 Grant or award Director acquired 7,828 shares (grant or award)
  12. 4 Grant or award Director acquired 7,828 shares (grant or award)
  13. 4 Grant or award Director acquired 7,828 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Chief Accounting Officer sold 2,218 shares at $6.76 ($15,000)
  18. 4 Open-market sale President and CEO sold 3,276 shares at $6.76 ($22,156)
  19. 4 Grant or award Director acquired 75,572 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 2 of 33 · 644 filings